The risks of death from ischaemic heart disease, cerebral haemorrhage, and thrombosis, and the risks of death from all causes have been estimated among the first degree relatives of male and female index patients with ischaemic heart disease. These risks have been compared with the figures published by the Registrar General for England and Wales and with the risks to relatives of a control group. It is considered that the Registrar General's figures provide the best comparison for mortality, but the control series provides useful comparison for morbidity.
There has been much speculation but little concrete evidence about the hereditary aspects of ischaemic heart disease. Gertler and White (I954) studied family histories of 97 male patients with coronary heart disease before 4I years, excluding hypertensive patients, and found an incidence of coronary heart disease which was twice as high amongst fathers of patients compared with controls, but less increase amongst mothers compared with their control sample. Thomas and Cohen (I955) studied family histories of 266 consecutive medical students at Johns Hopkins University and found a 4-fold increase amongst brothers of male patients.
In an extensive twin study, Harvald and Hauge (I963) found no difference in concordance rates for the occurrence of coronary occlusion between monozygotic and dizygotic twins of like sex, whereas dizygotic twins of unlike sex showed a significant difference. Rose-(i964 has morrecenly-reported. on family histories of IOO patients with ischaemic heart disease and found a 3-fold increase in mortality from ischaemic heart disease amongst parents of male patients and a higher mortality at all ages from unrelated illnesses. In these series there have been few female patients studied, and in some there has been a lack of documentary evidence Received August 8, I966. of the causes of mortality of the relatives, and it seems that the lack of evidence still prohibits definite conclusions as to risks to near relatives of patients with ischaemic heart disease.
We have collected pedigrees of nearly equal numbers of men and women with ischaemic heart disease and attempted to obtain documents of confirmation of every cause of death or serious morbidity in first degree relatives.
Subjects and Methods
Index Patients. The patients were I2I men and 96 women who had attended hospital with ischaemic heart disease; this was the only criterion for selection for the series. Diagnosis of ischaemic heart disease was made in each case on clinical evidence supported by ECG changes compatible with ischaemic heart disease. Male patients were all less than 6o years old and female patierts less than 70 at the onset of ischaemic heart disease. The patients were drawn from hospitals serving the central and north London areas and are shown in Table IA . Collection of the series of male patients continued over a period of 7 months at the Central Middlesex Hospital and over a further period of 8 months at the National Heart Hospital. Collection of women patients took longer and was carried out for 7 months at the Central Middlesex Hospital and a further I5 months at the National Heart Hospital and other hospitals in order to collect sufficient numbers for the series.
Controls. The group consisted of I04 men and io5-women.-95 men and 72 women-were-employees from the London Office of the Prudential Assurance Company; 3 men and i woman were hospital patients, 29 controls were wives of the patients, and 6 men and 3 women were medical colleagues (see Table IB ). All were within the same age range as the patients. None was aware of having ischaemic heart disease.
Famnily Histories. Pedigrees were drawn up to include every first degree relative ofpatients and controls. Permission to verify causes of death was requested 20-34, 35-44, 45-54, 55-64, 65-74, and 75 and over. From the tables then, the expected number of deaths amongst relatives was calculated in each category and at each age-group. The observed number of deaths was compared with the expected number of deaths in each age-group and expressed as a ratio. Tables of years 'at risk' were constructed for controls in the same way. There was no grouping of Tables in categories 420 and 94 (see Appendix I) in each age-group. The third column (O/E) gives the ratio of observed to expected numbers of deaths. The findings are summarized in Table VI.  Tables VA and VB show details of the results and demonstrate a progressively diminishing relative risk to relatives with increasing age of both patients and relatives. The numbers in the small groups are too small to be statistically significant. Table VI , however, with its broader grouping shows that there is a significantly increased risk of death from ischaemic heart disease to first degree relatives of patients. The observed increase is 61-fold amongst the 'younger' male relatives of the 'younger' female 42I, 422 , and 93 in the female relatives of patients with ischaemic heart disease. Table VIII shows a similar summary of cerebrovascular disorder in patients' relatives, using the Registrar General's categories 82a and b, and 97-I in 193I-39, 83a, b, and c in I940-49, and 33I and 332 from I950. The expected numbers and observed numbers are too small for significant comparison when considered in four groups divided by sex, but when comparison is made between the sum of the expected (5 86) and observed numbers (I4) in the 'younger' relatives of the 'younger' patients there is a more than 2-fold increase which is significant (p = <o-oi). Table IX shows a summary of the risks of death from all causes minus deaths from coronary artery disease, Registrar General's categories 94 in I93I-49 and 420 in 195o-present. When the risks of dying from coronary artery disease are subtracted from the risks of dying from all causes, the observed numbers of deaths are not significantly different from the expected numbers.
Risks of Death from Ischaemic Heart Disease and Cerebrovascular Disorders in Relatives of Controls. Table X shows the observed and expected deaths from ischaemic heart disease (Registrar General's categories 420 and 94) and from cerebral harmorrhage and thrombosis (Registrar General's categories 97-I, 82a and b, 83a, b, and c, 33I and 332) in the relatives of controls. The deaths observed from both ischaemic heart disease and cerebrovascular disorder in the relatives of the control series are close to those expected from the incidence in the general population. It is, therefore, Table XI shows the incidence of ischaemic heart disease and confirmed diabetes amongst living relatives (all ages included) of patients and controls. The pattern of increased incidence of ischaemic heart disease amongst the living relatives of patients follows closely the pattern of increased risk of death. A higher incidence of diabetes is found amongst the relatives of female patients compared with controls. The risks observed in our 'younger' series (to the nearest whole number) for male relatives of male index patients are i in I2, for male relatives of female index patients i in IO, for female relatives of male patients i in 36 and for female relatives of female patients i in 12. This represents an approximately 5-, 61-, 21-, and 7-fold increase over the general population, as seen in Table VI . There has been a substantial increase in risk in the general population during the period under review, but the series is not large enough to see if the relative increase in risk remains constant. There is, however, a suggestion that as the general risk increases the relative risk drops. Taking all relatives together, between I930 and I945 there were 7 deaths when o-6 would have been expected, whereas from I945 to i964, 27 deaths occurred when 4.9 would have been expected.
The female relatives of male patients show substantially less increase in risk of death from ischaemic heart disease than the other three classes of relatives. There is no indication that this is due to a reluctance to diagnose death from 'coronary artery disease' in young women, since there is no surplus of deaths of female relatives in categories 42I, 422, and 93. This suggests that the familial causes (whether genetic or common family environment) of ischaemic heart disease in many men are not such as to cause ischaemic heart disease in women; the causes in women, however, can certainly affect their brothers and fathers.
The increased deaths from cerebral haemorrhage and thrombosis in the sum of the 4 classes of 'younger' relatives show that some aetiological factors are common in this group of disorders and in ischaemic heart disease. We were not, however, able to confirm Rose's observation (I964) that relatives of patients with ischaemic heart disease tend to die earlier from 'all causes', but, unlike Rose's, our observations are restricted to adult life.
Familial concentrations may be due to genetic resemblance between relatives, to common family environment or, as is probably the case here, a mixture of both. Members of a family will tend to share environmental factors such as occupational class, diet, smoking, and exercise habits which have been shown to be related to the incidence of ischaemic heart disease. This will perhaps be true of sibs rather more than of parent and child. It is not easy to compare risks between parents and sibs of patients in this series, because deaths occurring a generation apart are subject to differences in both risks and classification. It seems likely, however, Table XII) showed a 13-fold increase in risk to their 'young' male relatives and a 23-fold increase in risk to the 'younger' female relatives, indicating a specially high risk to the 'younger' relatives in these families. When the life experience of the relatives of these 7 hypercholesterolaemic families is subtracted from the total series very little reduction in risk is shown amongst the male relatives over the general population; the female relatives show rather more reduction in the increased risk over the unselected series.
Summary
The health experience of all adult first degree relatives of 121 men and 96 women with ischaemic heart disease and I04 men and I05 women controls is reported. The causes of death and morbidity of both groups of relatives have been documented, and causes of death (from death certificates) have been classified by the Registrar General's staff using the criteria current at the date of death. A comparison has been made of deaths from ischaemic heart disease in the relatives of controls and the general population for England and Wales with the relatives of patients with ischaemic heart disease. When deaths under 55 years in men and 65 years in women are considered the relatives of both sexes of female patients with onset under 65 years show a nearly 7-fold increase compared with the general population and the male relatives of the male patients with onset under 55 years show an increase of risk of death which is 5 times that in the general population. The female relatives of the male patients experience an increased risk which is 2' times that of the women in the general population.
Family concentrations of ischaemic heart disease are noted especially in the families of the female patients and are most marked in the families of patients with hypercholesterolaemic xanthomatosis or amongst families containing members with diabetes. Two pairs of twins with ischaemic heart disease are mentioned.
The evidence points to an increased risk of ischaemic heart disease to relatives and suggests that the increased risk may be in part due to genetic factors. Table 17 193I-I939 Table 2I We thank Dr C. 0. Carter for guidance throughout the study; Dr J. A. Fraser Roberts, F.R.S., for encouragement in the initial stages; the Physicians of the Central Middlesex, the Elizabeth Garrett Anderson, the Middlesex, and the National Heart Hospitals who allowed us to question their patients, and the many practitioners and records officers who replied to our letters. We are much indebted to the Registrar General for classifying the death certificates. We are indebted to the patients and controls who allowed us to trace their relatives and especially the Prudential Assurance Company for their collaboration. Thomas 
